Abstract:Background: Intra-abdominal adhesions are a very common complication following abdominal surgery. Our previous studies have demonstrated that the inhibition of inflammation at the sites of peritoneal injury can prevent the formation of intra-abdominal adhesions. Resveratrol is a natural extract with a broad range of anti-inflammatory effects. Therefore, we propose that resveratrol can reduce the formation of intra-abdominal adhesions after surgery. The aim of this study was to investigate the effect of resveratrol on intra-abdominal adhesion prevention in a rat model with surgery-induced peritoneal adhesions. Materials and Methods: The cecum wall and its opposite parietal peritoneum were abraded following laparotomy to induce intra-abdominal adhesion formation. Varying doses of resveratrol were administered to the animals. On the eighth day after surgery, the adhesion score was assessed using a visual scoring system. Picrosirius red staining and a hydroxyproline assay were used to assess the amount of collagen deposition in the adhesion tissues. The levels of serum interleukin-6 (IL-6), tumor necrosis factor (TNF-α), and transforming growth factor beta-1 (TGF-β1) were determined by an enzyme-linked immunosorbent assay (ELISA). Western blotting was performed to determine the protein expression of TGF-β1, fibrinogen, and α-smooth muscle actin (α-SMA) in rat peritoneal adhesion tissue. Real-time RT-PCR was performed to quantify the mRNA expression of TGF-β1, fibrinogen, and α-SMA. Results: Resveratrol significantly reduced intra-abdominal adhesion formation and fibrin deposition in the rat model. Furthermore, resveratrol significantly reduced the serum levels of IL-6, TNF-α, and TGF-β1. The protein and mRNA expression of TGF-β1, fibrinogen, and α-SMA in the rat peritoneum and adhesion tissues were also down-regulated due to resveratrol intervention. Conclusion: Resveratrol can effectively prevent the formation of postoperative intra-abdominal adhesions in a rat model. This effect may be related to the suppression of inflammatory cytokine expression in the injured peritoneum by resveratrol. This study suggests that resveratrol may be a new and effective anti-adhesive agent that is worthy of further study and has potential application value.

Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model.

Resveratrol Attenuates Thromboxane A2 Receptor Agonist-Induced Platelet Activation by Reducing Phospholipase C Activity.

Splenic Artery Trunk Embolization Reduces the Surgical Risk of Liver Transplantation

Effect of Resveratrol on Microcirculation Disorder and Lung Injury Following Severe Acute Pancreatitis in Rats

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis

Pharmacologic Prophylaxis of Portal Venous System Thrombosis after Splenectomy: a Meta-Analysis.

The Suppressive Effect of Resveratrol on HIF-1α and VEGF Expression after Warm Ischemia and Reperfusion in Rat Liver.

The Incidence and Risk Factors of Portal Vein System Thrombosis after Splenectomy and Pericardial Devascularization.

Preventive use of low molecular weight heparin in portal vein system thrombosis after splenectomy without portal hypertension

Era of Liver Transplantation: Combined Anatomic Splenectomy and Anticoagulant Therapy in Prevention of Portal Vein Thrombosis after Splenectomy.

The Early Prevention and Treatment of PVST after Laparoscopic Splenectomy: A Prospective Cohort Study of 130 Patients.

Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinflammatory factors

Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.

Early Prophylactic Anticoagulation for Portal Vein System Thrombosis after Splenectomy: A Systematic Review and Meta-Analysis.

Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

Resveratrol inhibits hyperfibrinolysis and prolongs heart xenograft survival time in hamster-to-rat model

What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network meta-analysis

Effect of Resveratrol on the Prevention of Intra-Abdominal Adhesion Formation in a Rat Model

Rivaroxaban Versus Low-Molecular Weight Heparin Plus Warfarin Prevents Portal Vein System Thrombosis after Splenectomy and Pericardial Devascularization: A Randomized Clinical Trial.